Resultados: 4

    WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 mL or more within 24 hours after birth and affects about 5% of all women giving birth around the world. Globally, nearly one quarter of all maternal deaths are associated with PPH and, in most low-income countries, it is the main cau...

    WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth

    Postpartum haemorrhage (PPH) is commonly defined as a blood loss of 500 mL or more within 24 hours after birth and affects about 5% of all women giving birth around the world. Globally, nearly one quarter of all maternal deaths are associated with PPH and, in most low-income countries, it is the main cau...

    WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage

    The primary audience includes health professionals who are responsible for developing national and local health protocols (particularly those related to PPH) and those directly providing care to pregnant women and their newborns, including midwives, nurses, general medical practitioners, obstetricians, m...

    WHO guidelines for the management of postpartum haemorrhage and retained placenta

    One of the Millennium Development Goals set by the United Nations in 2000 is to reduce maternal mortality by three-quarters by 2015. If this is to be achieved, maternal deaths related to postpartum haemorrhage (PPH) must be significantly reduced. In support of this, health workers in developing countries...